이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Equasens Société anonyme 과거 수익 실적
과거 기준 확인 3/6
Equasens Société anonyme은 연평균 15.6%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 수입이 증가했으며, 연간 7.8%였습니다. 매출은 연평균 9.3%의 비율로 증가했습니다. Equasens Société anonyme의 자기자본이익률은 21.5%이고 순이익률은 21.4%입니다.
주요 정보
15.6%
수익 성장률
15.6%
EPS 성장률
Healthcare Services 산업 성장 | 21.0% |
매출 성장률 | 9.3% |
자기자본 수익률 | 21.5% |
순이익 | 21.4% |
다음 실적 업데이트 | 27 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01수익 및 비용 분석
수익 및 비용 분석
Equasens Société anonyme 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
31 Dec 23 | 220 | 47 | 0 | 0 |
30 Jun 23 | 223 | 48 | 0 | 0 |
31 Mar 23 | 219 | 47 | 0 | 0 |
31 Dec 22 | 214 | 46 | 0 | 0 |
30 Jun 22 | 203 | 42 | 0 | 0 |
31 Mar 22 | 198 | 41 | 0 | 0 |
31 Dec 21 | 193 | 39 | 0 | 0 |
30 Sep 21 | 190 | 37 | 0 | 0 |
30 Jun 21 | 188 | 35 | 0 | 0 |
31 Mar 21 | 180 | 33 | 0 | 0 |
31 Dec 20 | 172 | 31 | 0 | 0 |
30 Sep 20 | 166 | 29 | 0 | 0 |
30 Jun 20 | 160 | 27 | 0 | 0 |
31 Mar 20 | 159 | 27 | 0 | 0 |
31 Dec 19 | 159 | 27 | 0 | 0 |
30 Sep 19 | 156 | 27 | 0 | 0 |
30 Jun 19 | 153 | 26 | 0 | 0 |
31 Mar 19 | 151 | 26 | 0 | 0 |
31 Dec 18 | 148 | 25 | 0 | 0 |
30 Sep 18 | 144 | 25 | 0 | 0 |
30 Jun 18 | 139 | 24 | 0 | 0 |
31 Mar 18 | 134 | 24 | 0 | 0 |
31 Dec 17 | 130 | 23 | 0 | 0 |
30 Sep 17 | 129 | 22 | 0 | 0 |
30 Jun 17 | 128 | 21 | 0 | 0 |
31 Mar 17 | 128 | 21 | 0 | 0 |
31 Dec 16 | 128 | 21 | 0 | 0 |
30 Sep 16 | 125 | 20 | 0 | 0 |
30 Jun 16 | 121 | 20 | 0 | 0 |
31 Mar 16 | 117 | 19 | 0 | 0 |
31 Dec 15 | 113 | 19 | 0 | 0 |
30 Sep 15 | 113 | 18 | 0 | 0 |
30 Jun 15 | 112 | 18 | 0 | 0 |
31 Mar 15 | 113 | 17 | 0 | 0 |
31 Dec 14 | 115 | 17 | 0 | 0 |
30 Sep 14 | 114 | 17 | 0 | 0 |
30 Jun 14 | 113 | 16 | 0 | 0 |
31 Mar 14 | 113 | 16 | 0 | 0 |
31 Dec 13 | 113 | 16 | 0 | 0 |
30 Sep 13 | 113 | 15 | 0 | 0 |
30 Jun 13 | 113 | 15 | 0 | 0 |
양질의 수익: EQS 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: EQS 의 현재 순이익 이익률 (21.4%) 작년보다 낮습니다 (21.6%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: EQS 의 수입은 지난 5년 동안 매년 15.6% 씩 증가했습니다.
성장 가속화: 지난 1년간 EQS 의 수익 증가율( 1.7% )은 5년 평균( 15.6% 보다 낮습니다. 년도).
수익 대 산업: 지난 1년간 EQS 수익 성장( 1.7% )은 Healthcare Services 업계 8.6% 능가하지 못했습니다. 8.6%.
자기자본 수익률
높은 ROE: EQS 의 자본 수익률( 21.5% )은 높음으로 간주됩니다.